All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only ...

Building on that foundation, the GO Genomic Report generated through this workflow will now include a direct link to the WeTrials platform. With a single click, clinicians can move from a patient's ...

FibroBiologics is planning a prospective, multicenter, open-label clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to 12 ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Summary: Workplace attrition threatens operational continuity and clinical trial timelines for life science professionals. The recent shift to remote and decentralized trials presents unique ...

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

Discover how pre-stratification enables you to reduce clinical trial size without sacrificing statistical power.

Delaying onboarding until FDA approval reduces sunk-cost risk but can impede institutional learning and slow post-approval ...

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Evolving Landscape of Parenteral Anticancer Therapy–Associated Lung Toxicity: Incidence, Monitoring, and Management This scoping review was conducted based on the Arksey and O'Malley framework and the ...